Ethic Inc. Has $2.62 Million Stock Position in MKS Inc. $MKSI

Ethic Inc. increased its position in shares of MKS Inc. (NASDAQ:MKSIFree Report) by 19.3% in the fourth quarter, HoldingsChannel reports. The firm owned 16,366 shares of the scientific and technical instruments company’s stock after purchasing an additional 2,644 shares during the period. Ethic Inc.’s holdings in MKS were worth $2,615,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in MKSI. USA Financial Formulas acquired a new stake in shares of MKS during the 4th quarter worth about $26,000. Smartleaf Asset Management LLC increased its position in MKS by 74.5% in the 3rd quarter. Smartleaf Asset Management LLC now owns 260 shares of the scientific and technical instruments company’s stock valued at $32,000 after acquiring an additional 111 shares in the last quarter. Danske Bank A S acquired a new stake in MKS in the 3rd quarter valued at about $37,000. Winnow Wealth LLC acquired a new stake in MKS in the 3rd quarter valued at about $38,000. Finally, Northwestern Mutual Wealth Management Co. increased its position in MKS by 1,734.8% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 422 shares of the scientific and technical instruments company’s stock valued at $52,000 after acquiring an additional 399 shares in the last quarter. Institutional investors and hedge funds own 99.79% of the company’s stock.

Insider Activity at MKS

In other news, Director Elizabeth Mora sold 300 shares of MKS stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $239.44, for a total transaction of $71,832.00. Following the completion of the sale, the director owned 18,663 shares in the company, valued at $4,468,668.72. The trade was a 1.58% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jacqueline F. Moloney sold 340 shares of MKS stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $213.77, for a total transaction of $72,681.80. Following the sale, the director owned 10,393 shares of the company’s stock, valued at approximately $2,221,711.61. This represents a 3.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 68,503 shares of company stock worth $17,288,099 over the last 90 days. Insiders own 0.57% of the company’s stock.

MKS News Roundup

Here are the key news stories impacting MKS this week:

MKS Stock Up 2.1%

Shares of NASDAQ:MKSI opened at $319.71 on Tuesday. MKS Inc. has a one year low of $80.22 and a one year high of $326.83. The company has a 50 day moving average of $251.77 and a 200-day moving average of $208.07. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.11 and a quick ratio of 0.70. The stock has a market cap of $21.59 billion, a price-to-earnings ratio of 66.88, a P/E/G ratio of 1.62 and a beta of 1.98.

MKS (NASDAQ:MKSIGet Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.00 by $0.30. MKS had a net margin of 8.06% and a return on equity of 21.49%. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the previous year, the company earned $1.71 EPS. MKS’s revenue was up 15.2% on a year-over-year basis. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. On average, sell-side analysts forecast that MKS Inc. will post 10.2 earnings per share for the current year.

Analyst Ratings Changes

MKSI has been the subject of several research reports. Citigroup raised their price objective on shares of MKS from $290.00 to $355.00 and gave the company a “buy” rating in a research report on Friday. JPMorgan Chase & Co. raised their price objective on shares of MKS from $305.00 to $365.00 and gave the company an “overweight” rating in a research report on Friday. Wall Street Zen upgraded shares of MKS from a “buy” rating to a “strong-buy” rating in a research report on Saturday. TD Cowen restated a “buy” rating on shares of MKS in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $380.00 price objective on shares of MKS in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $317.23.

View Our Latest Stock Report on MKSI

MKS Company Profile

(Free Report)

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high?technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.

Featured Stories

Want to see what other hedge funds are holding MKSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MKS Inc. (NASDAQ:MKSIFree Report).

Institutional Ownership by Quarter for MKS (NASDAQ:MKSI)

Receive News & Ratings for MKS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS and related companies with MarketBeat.com's FREE daily email newsletter.